House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments
In Brief: ASCO Congratulates Klausner; UCLA Names Gasson Head Of Jonsson Center
Scientific Opportunity Should Guide Fund Allocation, House Says
House: NCI Should Coordinate National Cancer Program
ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer
ORI Finds Misconduct By CIT Professor
SAIC Frederick Offers Use Of Drug Facility
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?









